Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Biomaterials|May 6, 2015
Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedureMattias F Lindberg, Tony Le Gall, Nathalie Carmoy, et al.Acta Orthopaedica|November 25, 2024
Digital health literacy in Norwegian patients with hip and knee arthroplasty: normative data from a cross-sectional studyTurid Rognsvåg, Ingrid K Nordmo, Ingvild B Bergvad, et al.Molecular Metabolism|August 30, 2025
DYRK1A inhibition restores pancreatic functions and improves glucose metabolism in a preclinical model of type 2 diabetesRomane Bertrand, Stefania Tolu, Delphine Picot, et al.Frontiers in Neurology|March 28, 2019
Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau PhosphorylationRichard Rubenstein, Deep R Sharma, Binggong Chang, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 25, 2018
Improving carrier transport in Cu2O thin films by rapid thermal annealingKristin Bergum, Heine N Riise, Sandeep Gorantla, et al.Nature Communications|September 29, 2017
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse modelHenrik Jespersen, Mattias F Lindberg, Marco Donia, et al.Journal of Nanobiotechnology|April 30, 2017
A retro-inverso cell-penetrating peptide for siRNA deliveryAnaïs Vaissière, Gudrun Aldrian, Karidia Konate, et al.Biomaterials|June 8, 2012
The gene transfection properties of a lipophosphoramidate derivative with two phytanyl chainsMattias F Lindberg, Nathalie Carmoy, Tony Le Gall, et al.Cell Death & Disease|August 11, 2017
BET bromodomain inhibitors synergize with ATR inhibitors in melanomaSomsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, et al.Cell Death & Disease|December 15, 2017
BET bromodomain inhibitors synergize with ATR inhibitors in melanomaSomsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, et al.Pageof 10